Polypharmacy and the WHO third global patient safety challenge : Medication without harm and Scottish 7 step approach Alpana ana Mair, , Head d of Effect ectiv ive e Prescribi scribing ng & Therape peutics utics, Scottish tish Government ernment WHO polypharmac ypharmacy Lead d , Projec ject Coordi dina nator tor SIMP IMPATH THY, , @alpa panamair namair Effective Prescribing & Essential Blood Transfusion Safety Health Technologies
Otero MJ, Schmitt E. Clarifying terminology for adverse drug events. Ann. Intern. Med, 2005, 142:77-78.
▪ Worldwide, it is estimated that ▪ 50% of all medicines are inappropriately prescribed, dispensed or sold, and ▪ 50% of all patients fail to take their medicine properly 2004 Essential Blood Transfusion Safety Health Technologies
WHO Global Patient Safety Challenge Medication Without Harm Global Launch, 29 March 2017 Reduce the level of severe, avoidable harm related to medications by 50% over 5 years, globally Essential Blood Transfusion Safety Health Technologies
Domains and Key action areas High-risk situations Third Global Patient Safety Challenge: Medication Without Harm Transitions of Polypharmacy care
Advocacy Materials and Visual Identity http://www.who.int/patientsafety/medication-safety/en/
Early Priority Action Essential Blood Transfusion Safety Health Technologies
Urgency: Public health challenge : address @initiation & @review of medication 186 countries: 4% of total avoidable costs due to polypharmacy. Total of 0.3% global health expenditure could be saved = $18bn
Is polypill the answer?….
http://www.polypharmacy.scot.nhs.uk
Video – Medication Without Harm link to the video
Recommend
More recommend
